Life Biosciences is starting a clinical trial of its cellular reprogramming therapy in humans

Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time such therapy, which can reset the biological age of cells, is being introduced in humans.  Life Biosciences’ approach is partly based on the Yamanaka factors, a set of four transcription factors, namely Oct4, Sox2, Klf4, and […]